






If a DXA scan shows low bone density, or you’re post‑menopausal or on long-term steroids, vitamin K2 MK-4 with calcium citrate and vitamin D3 is a targeted stack. It’s useful when your Vitamin D, 25-Hydroxy is in the lower end of normal and you want a maintenance dose, not a repletion plan. Dairy-light eaters and adults with high bone turnover markers (P1NP and CTX, the lab signals of bone remodeling) are common fits.
MK-4 (a form of vitamin K2) activates osteocalcin and matrix Gla protein, the proteins that guide calcium into bone and keep it out of arteries. Clinical trials in Japan used multi‑milligram MK-4 to maintain bone density and reduce vertebral fractures. Vitamin D3 raises calcium absorption and keeps parathyroid hormone (the signal that pulls calcium from bone) in check. Calcium citrate supplies absorbable calcium and is gentler for people with sensitive stomachs.
Take 2 capsules twice daily with meals as directed; fat in a meal improves absorption of vitamin K2 MK-4 and vitamin D3, and splitting calcium improves uptake. The 25 mcg D3 is a maintenance dose; if your Vitamin D, 25-Hydroxy is low, repletion usually needs higher doses short term. The 200 mg calcium citrate here is supplemental, so count your diet to reach an appropriate daily total.
Do not use vitamin K2 MK-4 with warfarin or other vitamin K–antagonist blood thinners; it opposes their effect. Separate calcium from levothyroxine by 4 hours, and from tetracyclines or fluoroquinolones by at least 2–6 hours to avoid blocking absorption. Take calcium away from morning bisphosphonates. If you have high calcium, primary hyperparathyroidism, sarcoidosis, or significant kidney disease, talk with your clinician first.
MK-4 is the short-chain form used in Japanese osteoporosis trials at multi‑milligram doses. MK-7 has a longer half-life and is often used at microgram doses. For bone density, high-dose MK-4 has the most fracture data; MK-7 has solid carboxylation data but fewer fracture trials.
Bone turnover markers like P1NP and CTX can shift within 4–12 weeks. Meaningful changes in bone density on DXA are typically assessed over 6–12 months. Stay consistent and recheck labs and scans on that timeline with your clinician.
No. Vitamin K2 MK-4 counteracts warfarin and other vitamin K–antagonist anticoagulants. If you need vitamin K while anticoagulated, that requires clinician-managed dosing and INR monitoring. Do not start on your own.
If your Vitamin D, 25-Hydroxy is low, you’ll likely need a higher short-term D3 dose than the 25 mcg here, then step down to maintenance. Get your level checked and follow a repletion plan from your clinician.
Take with meals and split doses, which improves absorption and reduces stomach upset. Separate by 4 hours from levothyroxine, and by at least 2–6 hours from tetracyclines or fluoroquinolone antibiotics to avoid blocking their absorption.
High-dose MK-4 hasn’t been established as safe in pregnancy or breastfeeding. Stick to prenatal-vitamin levels of vitamin K unless your OB advises otherwise. Calcium and vitamin D needs may rise; discuss targeted dosing with your clinician.
Often yes, as an adjunct. Take bisphosphonates first thing with water and no calcium; add calcium and vitamin D3 later with meals. Bring all supplements to your bone clinic so dosing and timing fit your prescription.
Track Vitamin D, 25-Hydroxy for dose adequacy, serum calcium to avoid excess, and bone turnover markers (P1NP and CTX) to gauge response. Your long-term outcome is best assessed by DXA at 1–2 year intervals.



